FDA Adverse Event Injury Summary report: N

UNKNOWN_CORK_PRODUCT

MDR report key: 5014301 · Received August 19, 2015

Report

Report Number
0002249697-2015-02724
Event Type
Injury
Date Received
August 19, 2015
Date of Event
May 1, 2014
Report Date
July 23, 2015
Manufacturer
STRYKER ORTHOPAEDICS-MAHWAH
Product Code
MEH
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE CATALOG NUMBER AND LOT CODE WERE NOT PROVIDED. THE DEVICE WAS REPORTED AS AN UNKNOWN ACCOLADE STEM. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND IF RECEIVED, WILL BE PROVIDED IN THE SUPPLEMENTAL REPORT UPON COMPLETION OF THE INVESTIGATION. OTHER TEXT : NOT AVAILABLE

Description of Event or Problem · 1

THIS EVENT PERTAINS TO THE PATIENT'S RIGHT HIP. A (B)(6) FEMALE PRESENTED TO OUTPATIENTS WITH BILATERAL THIGH PAIN IN (B)(6) 2013. SHE HAD UNDERGONE STAGED BILATERAL HIP REPLACEMENTS FOR OSTEOARTHRITIS. BOTH HIPS WERE REPLACED WITH 36MM COCR ON POLYETHYLENE ACCOLADE-TRIDENT THR'S. THE RIGHT HIP WAS REPLACED IN 2011 AND THE LEFT A YEAR LATER. 6 MONTHS AFTER THE LEFT THR BOTH HIPS BECAME PAINFUL. THE PATIENT UNDERWENT REVISION RIGHT THR IN (B)(6) 2014 TO A SIZE 12 HIGH OFFSET JRI STEM, WITH STANDARD 36 CERAMIC HEAD, SIZE 56 LIMA SHELL WITH 36MM ID CERAMIC LINER. BACKGROUND: IMMEDIATE FINDINGS: RADIOGRAPHS DEMONSTRATED LYSIS OF THE FEMORAL COMPONENT BILATERALLY (GRUEN ZONES 1 & 7). INFLAMMATORY MARKERS WERE NORMAL. MULTIPLE BIOPSIES DEMONSTRATED NO GROWTH UNDER MICROSCOPY, CULTURE AND STAINING. CRP WAS 2MG/DL, COBALT 140NMOL/L AND CHROMIUM 12.1NMOL/L. MRI OF BOTH HIPS DEMONSTRATED LARGE VOLUME TROCHANTERIC FLUID COLLECTIONS BILATERALLY (OXFORD TYPE II )[6]. INITIAL ION LEVELS SHOWED A COBALT LEVEL OF 140NMOL/L WHICH WERE REPEATED AND SHOWED AGAIN AN ELEVATED COBALT 161NMOL/L AND CHROMIUM 12.1NMOL/L.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
548945 UNKNOWN_CORK_PRODUCT IMPLANT MEH STRYKER ORTHOPAEDICS-MAHWAH UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 65 YR Hospitalization| R